Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. sophomore Avg
|
|
New words:
Academy, Alane, Babu, basket, blood, cell, COBRA, comparison, Consortium, Constructive, Dr, EAACI, EmpaveliTM, entirety, Excellence, fewer, fibrodysplasia, glomerulopathy, hereto, Hybrid, IgA, Immunology, Israeli, joined, longest, Neopharm, nephropathy, progressiva, purport, red, rollover, Scottish, Sheridan, text, underway, unvested, upcoming, William, Yarlagadda
Removed:
animal, buy, de, demonstrated, dose, LDH, PoC, supported, treat, vitro, Zika
Filing tables
Filing exhibits
Related press release
Associated BCRX transcripts
BCRX similar filings
Filing view
External links
